Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Operating activities
Net income (loss)	$ 7,363	$ 9,289
Adjustments to reconcile to net cash used in operating activities:
Depreciation and amortization	47,316	31,314
Amortization of debt issue costs	1,662	1,419
Extinguishment of debt	0	3,395
Stock-based compensation	5,441	445
Compensation expense related to employee share purchases	427	0
Change in fair value of earnout liabilities	(646)	(3,948)
Gain on sale of rental equipment	(1,929)	(2,463)
Gain on sale of property, plant and equipment	(86)	0
Charge for step-up of acquired inventory	2,866	2,703
Net realizable value and reserve adjustment for obsolete and excess inventory	0	5,551
Bad debt expense	1,045	564
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable	(8,329)	(30,795)
Inventories	9,639	(43,857)
Prepaid expenses and other current assets	(7,288)	(2,224)
Accounts payable	10,552	1,687
Accrued expenses and other current liabilities	5,587	1,316
Other changes in operating assets and liabilities	433	6,324
Net cash provided by (used in) operating activities	74,053	(19,280)
Investing activities
Purchases of property, plant and equipment	(11,180)	(4,954)
Business acquisitions, net of cash acquired	(252,007)	(113,681)
Purchases of rental equipment	(7,735)	(7,913)
Proceeds from sale of rental equipment	4,202	5,998
Net cash provided by (used in) investing activities	(266,720)	(120,550)
Financing activities
Proceeds from revolving lines of credit	174,587	302,044
Payments on revolving lines of credit	(295,816)	(237,370)
Proceeds from term loans	305,000	445,630
Payments on term loans	(11,250)	(343,662)
Deferred financing costs	(3,419)	(11,956)
Proceeds from rights offering, net of offering costs of $1,531	98,469	0
Repurchase of common stock	0	(1,940)
Shares repurchased held in treasury	(171)	(469)
Proceeds from employees for share purchases	3,253	0
Payment of financing lease principal	(358)	(457)
Payment of earnout	(1,000)	0
Net cash provided by (used in) financing activities	269,295	151,820
Effect of exchange rate changes on cash and cash equivalents	(209)	(1,309)
Increase (decrease) in cash, cash equivalents and restricted cash	76,419	10,681
Cash, cash equivalents and restricted cash at beginning of period	24,740	14,671
Cash, cash equivalents and restricted cash at end of period	101,159	25,352
Cash and cash equivalents	80,456	25,171
Restricted cash	20,703	181
Total cash, cash equivalents and restricted cash	101,159	25,352
Supplemental disclosure of cash flow information
Net cash paid for income taxes	9,370	11,553
Net cash paid for interest	26,187	12,093
Net cash paid for interest on supply chain financing	1,753	579
Fair value of common stock exchanged for reverse acquisition	0	351,491
Settlement of related party obligations	0	5,276
Additions of property, plant and equipment included in accounts payable	521	73
Right of use assets obtained in exchange for finance lease liabilities	396	886
Right of use assets obtained in exchange for operating lease liabilities	$ 19,879	$ 12,773